Highbridge Capital Management LLC has filed its 13F form on February 12, 2025 for Q4 2024 where it was disclosed a total value porftolio of $435 Million distributed in 304 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Hess Corp with a value of $77.1M, Allete Inc with a value of $54.6M, Summit Materials, Inc. with a value of $38.1M, Frontier Communications Parent, Inc. with a value of $37.6M, and Amedisys Inc with a value of $34.6M.
Examining the 13F form we can see an increase of $102M in the current position value, from $333M to 435M .
Highbridge Capital Management LLC is based out at New York, NY
Below you can find more details about Highbridge Capital Management LLC portfolio as well as his latest detailed transactions.
Portfolio value
$435 Million
$79.8 Million
$77.1 Million
$54.6 Million
$54 Million
$50.3 Million
$38.1 Million
$36.7 Million
$34.6 Million
$5.9 Million
Stock Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Added 89.36%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 21.11%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 60.06%
-
$0
0.0% of portfolio
-
Q4 2024
Added 21.99%
$420M
$6,000
0.0% of portfolio
575
Q1 2021
New
Roman Dbdr Acquisition Corp
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 28.1%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
Oaktree Acquisition Corp Iii
-
$0
0.0% of portfolio
-
Q4 2024
New
Horizon Space Acqustn I Corp
-
$0
0.0% of portfolio
-
Q1 2023
Reduced 42.79%
Churchill Capital Corp Ix
-
$0
0.0% of portfolio
-
Q2 2024
New
Brightspring Health Svcs Inc
-
$0
0.0% of portfolio
-
Q4 2024
Added 0.33%
Bridger Aerospace Grp Hldgs
-
$0
0.0% of portfolio
-
Q3 2024
Added 8.5%
Brand Engagement Network Inc
-
$0
0.0% of portfolio
-
Q3 2024
Added 23.26%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
Added 2.19%
-
$0
0.0% of portfolio
-
Q3 2024
New
Bold Eagle Acquisition Corp
-
$0
0.0% of portfolio
-
Q4 2024
New
Bold Eagle Acquisition Corp
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Added 48.63%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
New
Black Spade Acquisition Ii C
-
$0
0.0% of portfolio
-
Q4 2024
New
Black Spade Acquisition Ii C
-
$0
0.0% of portfolio
-
Q4 2024
New
Black Hawk Acquisition Corp
-
$0
0.0% of portfolio
-
Q3 2024
Added 13.67%
Bukit Jalil Gbl Acquisition
-
$0
0.0% of portfolio
-
Q3 2023
New
Bukit Jalil Gbl Acquisition
-
$0
0.0% of portfolio
-
Q1 2024
Added 0.04%
-
$0
0.0% of portfolio
-
Q1 2024
Added 13.2%
Chenghe Acquisition Ii CO
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 157.86%
Charlton Aria Acquisition CO
-
$0
0.0% of portfolio
-
Q4 2024
New
Charlton Aria Acquisition CO
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 67.39%
-
$0
0.0% of portfolio
-
Q4 2024
Added 16.92%
Centurion Acquisition Corp
-
$0
0.0% of portfolio
-
Q3 2024
New
Centurion Acquisition Corp
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 22.47%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 34.36%
Cantor Equity Partners Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
Calidi Biotherapeutics Inc
-
$0
0.0% of portfolio
-
Q4 2024
Added 100.02%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 15.69%
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 4.34%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Added 13.63%
